Generics - Pharmaceutical

Filter

Current filters:

Pharmaceutical

Popular Filters

176 to 200 of 469 results

EMA focuses on new legislation, increased efficiency and transparency in 2013 work program

13-03-2013

The European Medicines Agency has published its work program for 2013. This year, the Agency's priorities…

BiotechnologyEuropeGenericsPharmaceuticalRegulation

Hikma delivers revenue growth of 21% and EPS up 24% for 2012

13-03-2013

Jordon-headquartered Hikma Pharmaceuticals (LSE: HIK) has reported preliminary results for 2012, showing…

FinancialGenericsHikma PharmaceuticalsPharmaceutical

Experts to examine opportunities in growing African pharmaceutical market

12-03-2013

"At a time when growth in traditional pharmaceutical markets is stalling, strong macroeconomic fundamentals…

GenericsMarkets & MarketingPharmaceuticalRegulationRest of the World

Indian Pharma growth outpaces rivals, but must embrace innovation

12-03-2013

Ranking among the top five globally by production volume, the Indian pharmaceutical market at present…

Asia-PacificBiotechnologyGenericsMarkets & MarketingPharmaceuticalProductionResearch

Thailand flouts pharmaceutical patent protection; report

08-03-2013

Lax enforcement of patent regulations in Thailand is alienating American intellectual property laws,…

Asia-PacificGenericsMarkets & MarketingPatentsPharmaceutical

Further savings expected following Australian Crestor patent decision, says GMiA

07-03-2013

In a decision brought down by the Australian Federal Court earlier this week, suppliers of generic medicines…

Asia-PacificAstraZenecaCardio-vascularCrestorGenericsPatentsPharmaceuticalPricing

Par Pharma agrees $45 million settlement over off-label Megace ES promotion

07-03-2013

US generic drugmaker Par Pharmaceutical NYSE: PRX) pleaded guilty in federal court yesterday (March 6)…

FinancialGenericsLegalMarkets & MarketingMegace ESMetabolicsNorth AmericaPar PharmaceuticalPharmaceutical

Anti-infective market in sub-Saharan Africa set to reach $377 million in 2018

05-03-2013

The high incidence of infectious diseases in sub-Saharan Africa is expected to sustain the demand for…

Antibiotics and Infectious diseasesGenericsMarkets & MarketingPharmaceuticalRest of the World

Indian patent appeal board upholds compulsory license on Bayer's Nexavar

05-03-2013

After much delay, the verdict into German pharmaceutical major Bayer's (BAYN: DE) appeal against the…

Asia-PacificBayerGenericsNatco PharmaNexavarOncologyPatentsPharmaceutical

Hikma leaps as it confirms unsolicited interest in Injectables business

04-03-2013

Jordanian drugmaker Hikma Pharmaceuticals (LSE: HIK) saw its shares jump 8.1% to£9.365 on Friday,…

FinancialGenericsHikma PharmaceuticalsMergers & AcquisitionsPharmaceutical

New US Federal Trade Commission chairman - Edith Ramirez - to be designated by President

03-03-2013

President Barack Obama intends to designate Edith Ramirez as Chairman of the Federal Trade Commission…

BiotechnologyGenericsManagementNorth AmericaPharmaceuticalRegulation

India's Cipla ups bid for Cipla Medpro now seeking 100% control for around $512 million

01-03-2013

Indian drugmaker Cipla (BSE: 500087) has made an offer to the shareholders of Cipla Medpro South Africa…

CiplaCipla MedproGenericsMarkets & MarketingPharmaceutical

Russian government to develop domestic production of vaccines

01-03-2013

The Russian government is considering investing in the domestic production of vaccines, by building a…

EuropeFinancialGenericsPharmaceuticalProductionVaccines

Medicines Patent Pool and ViiV Healthcare collaborate to treat pediatric HIV

28-02-2013

The Medicines Patent Pool (MPP) this week announced the launch of a new collaboration with ViiV Healthcare…

AbacavirAnti-viralsGenericsGlobalPatentsPharmaceuticalViiV Healthcare

PHARMAC holding back New Zealand health care industry growth, says GlobalData

26-02-2013

Despite disproportionate elderly population growth and an unsaturated market acting as key drivers, growth…

Asia-PacificGenericsMarkets & MarketingPharmaceuticalPricing

Briefs: Ablynx inks research deal with Spirogen; Solent Pharma debuts

25-02-2013

Belgium drug developer Ablynx (Euronext Brussels: ABLX]) has entered into a research collaboration with…

AblynxGenericsidebenoneIdecortexLicensingMarkets & MarketingNeurologicalOncologyPharmaceuticalResearchSolent PharmaSpirogen

Australian trade groups argue over how increasing generic drug use drives savings

25-02-2013

While there is no difference when it comes to safety, efficacy and quality, there is a difference when…

Asia-PacificFinancialGenericsHealthcarePharmaceutical

Indian pharma excipients distributor IndChem acquired by Dutch firm IMCD

20-02-2013

Netherlands-based conglomerate IMCD Group BV has acquired the business of IndChem International, an established…

GenericsIMCD GroupIndChemMergers & AcquisitionsPharmaceutical

South African pharma market set to grow to $7 billion in 2018

19-02-2013

South Africa's pharmaceutical market is one of the most attractive markets in Africa. Some of the main…

GenericsMarkets & MarketingPharmaceuticalRegulationRest of the World

Ukraine pharma industry appeals to President on some new drug law provisions

18-02-2013

Ukraine's Association of Pharmaceutical Research and Development, APRAD, has written to the country's…

EuropeGenericsLegalPharmaceuticalPolitics

Global Pharma may leave Russian market due to protectionist policies

17-02-2013

The planned imposition of restrictions for the public purchase of imported drugs, initiated by the Russian…

EuropeGenericsMarkets & MarketingPharmaceuticalPoliticsRegulation

Drugmakers to continue facing growing generic competition in 2013

17-02-2013

Last year saw the expiration of patents for several blockbuster drugs, leading to increasing generic…

AmarinFinancialForest LaboratoriesGenericsPatentsPharmaceutical

Merck & Co to pay $688 million to settle investor law suits; Teva could face $2.1 billion damages

15-02-2013

US pharma giant Merck & Co (NYSE: MRK) said yesterday that it has reached an agreement in principle with…

FinancialGenericsLegalMerck & CoPharmaceuticalProtonixTeva Pharmaceutical IndustriesVytorinZetia

176 to 200 of 469 results

Back to top